Brief: Hofseth Biocare Q3 EBITDA loss narrows to NOK 6.3 mln
Nov 15 (Reuters) - HOFSETH BIOCARE ASA HOFBC.OL :
* Q3 OPERATING REVENUE NOK 27.9 MILLION VERSUS NOK 3.6
MILLION
YEAR AGO
* Q3 EBITDA LOSS NOK 6.3 MILLION VERSUS LOSS NOK 41.2
MILLION
YEAR AGO
* PRODUCED 665 TONS OF FINISHED PRODUCTS DURING Q3 OF 2017,
UP 10
PER CENT FROM LAST QUARTER
Source text for Eikon: ID:nGNE5GHcPk
Further company coverage: HOFBC.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering